Regulation & law · 05/09/2017Updated: 10/17/2026 · 1 min read
National Cancer Institute to Grant Exclusive Patent License to Nanobernetics for Microarray Binding Sensors
Summary
The National Institutes of Health is considering granting an exclusive patent license to Nanobernetics, a Maryland-based company, to commercialize a patent for microarray binding sensors using carbon nanotube transistors.
Original source language: Federal Register — All DocumentsOpen original release →